Overview

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises:...

Open

$0.00

Prior close

$176.94

Today's high

$0.00

Today's low

$0.00

52 Week high

$198.87

52 Week low

$100.99

News

GlobeNewsWire • 4 days ago • RGEN

Repligen Announces $1 Billion Private Convertible Senior Notes Transaction

Seeking Alpha • 4 days ago • RGEN

Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells

Seeking Alpha • 6 days ago • RGEN

Repligen Corporation (RGEN) Q3 2026 Earnings Call Transcript

MarketBeat • 6 days ago • RGEN

What Repligen (RGEN) Said on Its Q3 Earnings Call

Seeking Alpha • 6 days ago • RGEN

Conestoga Small Cap Composite Q3 2026 Portfolio Activity